S 765
118th Congress
Senate
Health
Cancer
Genetics
Health care coverage and access
Health promotion and preventive care
Hereditary and development disorders
Medical tests and diagnostic methods
Medicare
Reducing Hereditary Cancer Act of 2023
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 9, 2023
Read twice and referred to the Committee on Finance.
Mar 9, 2023
Introduced in Senate
Plain-English summary
Reducing Hereditary Cancer Act of 2023
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1
Cosponsors
1